Inhibition of BMP9 can downregulate Smad1/5 via ALK-1 thereby downregulating ATOH8, promoting HIF-2α expression and exacerbating hypoxia in pulmonary hypertension (Morikawa et al. 2019). This evidence concerns the gene SMAD1 and pulmonary arterial hypertension.